Harvey Capital Management Inc Aquestive Therapeutics, Inc. Transaction History
Harvey Capital Management Inc
- $380 Million
- Q1 2025
A detailed history of Harvey Capital Management Inc transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Harvey Capital Management Inc holds 499,570 shares of AQST stock, worth $1.47 Million. This represents 0.38% of its overall portfolio holdings.
Number of Shares
499,570
Previous 267,390
86.83%
Holding current value
$1.47 Million
Previous $946,000
53.07%
% of portfolio
0.38%
Previous 0.22%
Shares
3 transactions
Others Institutions Holding AQST
# of Institutions
124Shares Held
43.5MCall Options Held
504KPut Options Held
148K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$28.8 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$16 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.35MShares$12.8 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY2.63MShares$7.73 Million1.54% of portfolio
-
Franklin Resources Inc San Mateo, CA2.13MShares$6.28 Million0.0% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $157M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...